Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent
Gespeichert in:
| Veröffentlicht in: | International journal of laboratory hematology 2022-04, Vol.44 (2), p.e72-e75 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e75 |
|---|---|
| container_issue | 2 |
| container_start_page | e72 |
| container_title | International journal of laboratory hematology |
| container_volume | 44 |
| creator | Kaneko, Yousuke Sugasaki, Motoki Okada, Naoto Niimi, Mako Yasui, Saya Hori, Taiki Aihara, Ken‐ichi Takishita, Makoto Abe, Masahiro Nakamura, Shingen |
| description | |
| doi_str_mv | 10.1111/ijlh.13718 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2577733287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2577733287</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3578-8a752e810ad9f793adc8d95b7af6a372b72d23c8c1ba167b206ea4f54ec17cd03</originalsourceid><addsrcrecordid>eNp9kU1vGyEQhlHUqvloL_kBEVIvVRSnfCwLPlpRm6Sy1Esr9YZmWdbGYRcH2Eb-HfnDZeM0qnIol2HgmZcZXoROKbmkZX12G7--pFxSdYCOqBR0JgT_9eZlz-ghOk5pQ4iQFZm_Q4e8Eqow5Ag9LmJ2HZg8gsfbGHwYVpBdGHDocF5bXK7cb8i2xVsoaKHyOoa-CVsPKbsBZ9db3Oww9O4OTDkIEa_skEs-ZQ8ur7H1HlbOFDHXXuBmzHgIGSfnnYF_XogWpsr36G0HPtkPz_EE_fz65cfVzWz5_fr2arGcGS6kmimQgllFCbTzTs45tEa1c9FI6GrgkjWStYwbZWgDtJYNI7WFqhOVNVSalvAT9GmvW-a-H23KunfJTL0ONoxJMyGl5JwpWdCPr9BNGONQutOsLn9aMaLqQp3vKRNDStF2ehtdD3GnKdGTVXqySj9ZVeCzZ8mx6W37gv71pgB0Dzw4b3f_kdK335Y3e9E_LuShcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2640942086</pqid></control><display><type>article</type><title>Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Kaneko, Yousuke ; Sugasaki, Motoki ; Okada, Naoto ; Niimi, Mako ; Yasui, Saya ; Hori, Taiki ; Aihara, Ken‐ichi ; Takishita, Makoto ; Abe, Masahiro ; Nakamura, Shingen</creator><creatorcontrib>Kaneko, Yousuke ; Sugasaki, Motoki ; Okada, Naoto ; Niimi, Mako ; Yasui, Saya ; Hori, Taiki ; Aihara, Ken‐ichi ; Takishita, Makoto ; Abe, Masahiro ; Nakamura, Shingen</creatorcontrib><identifier>ISSN: 1751-5521</identifier><identifier>EISSN: 1751-553X</identifier><identifier>DOI: 10.1111/ijlh.13718</identifier><identifier>PMID: 34585530</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>activated partial thromboplastin time ; Amikacin ; Amikacin - pharmacology ; aminoglycosides ; Anti-Bacterial Agents - pharmacology ; Ellagic Acid ; Gentamicin ; Gentamicins - pharmacology ; Humans ; Indicators and Reagents ; Partial Thromboplastin Time ; silica ; Silicon Dioxide ; Thromboplastin</subject><ispartof>International journal of laboratory hematology, 2022-04, Vol.44 (2), p.e72-e75</ispartof><rights>2021 John Wiley & Sons Ltd</rights><rights>Copyright © 2022 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3578-8a752e810ad9f793adc8d95b7af6a372b72d23c8c1ba167b206ea4f54ec17cd03</citedby><cites>FETCH-LOGICAL-c3578-8a752e810ad9f793adc8d95b7af6a372b72d23c8c1ba167b206ea4f54ec17cd03</cites><orcidid>0000-0002-5213-5770</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijlh.13718$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijlh.13718$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34585530$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaneko, Yousuke</creatorcontrib><creatorcontrib>Sugasaki, Motoki</creatorcontrib><creatorcontrib>Okada, Naoto</creatorcontrib><creatorcontrib>Niimi, Mako</creatorcontrib><creatorcontrib>Yasui, Saya</creatorcontrib><creatorcontrib>Hori, Taiki</creatorcontrib><creatorcontrib>Aihara, Ken‐ichi</creatorcontrib><creatorcontrib>Takishita, Makoto</creatorcontrib><creatorcontrib>Abe, Masahiro</creatorcontrib><creatorcontrib>Nakamura, Shingen</creatorcontrib><title>Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent</title><title>International journal of laboratory hematology</title><addtitle>Int J Lab Hematol</addtitle><subject>activated partial thromboplastin time</subject><subject>Amikacin</subject><subject>Amikacin - pharmacology</subject><subject>aminoglycosides</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Ellagic Acid</subject><subject>Gentamicin</subject><subject>Gentamicins - pharmacology</subject><subject>Humans</subject><subject>Indicators and Reagents</subject><subject>Partial Thromboplastin Time</subject><subject>silica</subject><subject>Silicon Dioxide</subject><subject>Thromboplastin</subject><issn>1751-5521</issn><issn>1751-553X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1vGyEQhlHUqvloL_kBEVIvVRSnfCwLPlpRm6Sy1Esr9YZmWdbGYRcH2Eb-HfnDZeM0qnIol2HgmZcZXoROKbmkZX12G7--pFxSdYCOqBR0JgT_9eZlz-ghOk5pQ4iQFZm_Q4e8Eqow5Ag9LmJ2HZg8gsfbGHwYVpBdGHDocF5bXK7cb8i2xVsoaKHyOoa-CVsPKbsBZ9db3Oww9O4OTDkIEa_skEs-ZQ8ur7H1HlbOFDHXXuBmzHgIGSfnnYF_XogWpsr36G0HPtkPz_EE_fz65cfVzWz5_fr2arGcGS6kmimQgllFCbTzTs45tEa1c9FI6GrgkjWStYwbZWgDtJYNI7WFqhOVNVSalvAT9GmvW-a-H23KunfJTL0ONoxJMyGl5JwpWdCPr9BNGONQutOsLn9aMaLqQp3vKRNDStF2ehtdD3GnKdGTVXqySj9ZVeCzZ8mx6W37gv71pgB0Dzw4b3f_kdK335Y3e9E_LuShcw</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Kaneko, Yousuke</creator><creator>Sugasaki, Motoki</creator><creator>Okada, Naoto</creator><creator>Niimi, Mako</creator><creator>Yasui, Saya</creator><creator>Hori, Taiki</creator><creator>Aihara, Ken‐ichi</creator><creator>Takishita, Makoto</creator><creator>Abe, Masahiro</creator><creator>Nakamura, Shingen</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5213-5770</orcidid></search><sort><creationdate>202204</creationdate><title>Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent</title><author>Kaneko, Yousuke ; Sugasaki, Motoki ; Okada, Naoto ; Niimi, Mako ; Yasui, Saya ; Hori, Taiki ; Aihara, Ken‐ichi ; Takishita, Makoto ; Abe, Masahiro ; Nakamura, Shingen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3578-8a752e810ad9f793adc8d95b7af6a372b72d23c8c1ba167b206ea4f54ec17cd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>activated partial thromboplastin time</topic><topic>Amikacin</topic><topic>Amikacin - pharmacology</topic><topic>aminoglycosides</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Ellagic Acid</topic><topic>Gentamicin</topic><topic>Gentamicins - pharmacology</topic><topic>Humans</topic><topic>Indicators and Reagents</topic><topic>Partial Thromboplastin Time</topic><topic>silica</topic><topic>Silicon Dioxide</topic><topic>Thromboplastin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaneko, Yousuke</creatorcontrib><creatorcontrib>Sugasaki, Motoki</creatorcontrib><creatorcontrib>Okada, Naoto</creatorcontrib><creatorcontrib>Niimi, Mako</creatorcontrib><creatorcontrib>Yasui, Saya</creatorcontrib><creatorcontrib>Hori, Taiki</creatorcontrib><creatorcontrib>Aihara, Ken‐ichi</creatorcontrib><creatorcontrib>Takishita, Makoto</creatorcontrib><creatorcontrib>Abe, Masahiro</creatorcontrib><creatorcontrib>Nakamura, Shingen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of laboratory hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaneko, Yousuke</au><au>Sugasaki, Motoki</au><au>Okada, Naoto</au><au>Niimi, Mako</au><au>Yasui, Saya</au><au>Hori, Taiki</au><au>Aihara, Ken‐ichi</au><au>Takishita, Makoto</au><au>Abe, Masahiro</au><au>Nakamura, Shingen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent</atitle><jtitle>International journal of laboratory hematology</jtitle><addtitle>Int J Lab Hematol</addtitle><date>2022-04</date><risdate>2022</risdate><volume>44</volume><issue>2</issue><spage>e72</spage><epage>e75</epage><pages>e72-e75</pages><issn>1751-5521</issn><eissn>1751-553X</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34585530</pmid><doi>10.1111/ijlh.13718</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-5213-5770</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1751-5521 |
| ispartof | International journal of laboratory hematology, 2022-04, Vol.44 (2), p.e72-e75 |
| issn | 1751-5521 1751-553X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2577733287 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | activated partial thromboplastin time Amikacin Amikacin - pharmacology aminoglycosides Anti-Bacterial Agents - pharmacology Ellagic Acid Gentamicin Gentamicins - pharmacology Humans Indicators and Reagents Partial Thromboplastin Time silica Silicon Dioxide Thromboplastin |
| title | Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T03%3A37%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Artifactual%20prolongation%20of%20the%20activated%20partial%20thromboplastin%20time%20by%20amikacin%20or%20gentamicin%20with%20ellagic%20acid,%20but%20not%20silica%20activated%20reagent&rft.jtitle=International%20journal%20of%20laboratory%20hematology&rft.au=Kaneko,%20Yousuke&rft.date=2022-04&rft.volume=44&rft.issue=2&rft.spage=e72&rft.epage=e75&rft.pages=e72-e75&rft.issn=1751-5521&rft.eissn=1751-553X&rft_id=info:doi/10.1111/ijlh.13718&rft_dat=%3Cproquest_cross%3E2577733287%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2640942086&rft_id=info:pmid/34585530&rfr_iscdi=true |